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Retrospective cohort study 2
Characteristics of acutely infected CHIKV patients with neurological symptoms 3
Among the 129 CHIKV-infected patients with CNS disease, biological analysis of the CSF 4 was positive for 55 CHIKV RNA or 30 anti-CHIKV IgM, in 78 patients and negative in 51 5 patients ( Figure 1 ). 6
We excluded nine patients because they exhibited additional conditions, which invalidated 7 CHIKV as a unique cause for the neurological symptoms. Briefly, these consisted in 8 encephalopathy of primary metabolic origin (n=3), alcohol-related encephalopathy (n=3), 9 posterior reversible encephalopathy syndrome in systemic lupus erythematosus (n=1), 10 Streptococcus pneumoniae meningitis (n=1), and neurocysticercosis (n=1). The 69 remaining 11 patients showed at least one IEC encephalitis criteria but 12 of them were excluded because 12 incomplete charts did not allow definite classification. Thus, a total of 57 patients diagnosed 13
with CHIKV-associated CNS disease were enrolled in the study. Among them, 24 (42.1%) 14 patients with altered mental status matched IEC encephalitis definition, whereas 33 (57.9%) 15 others did not and were designated as NECACD in further analysis. 16 We identified six confirmed cases of CHIKV-associated encephalitis (i.e., altered mental 17 status plus at least three minor criteria), while 18 patients were classified as possible cases 18 (i.e., two minor criteria). Both groups shared the same clinical and biological profiles, which 19 confirmed the appropriateness of the IEC classification that allow these groups to be pooled 20 for case registration (data not shown). 21
As expected, CHIKV encephalitic cases were more likely to exhibit severe CNS disease, 22 than cases of NECACD, which consisted almost exclusively in mild to moderate behavioral 23 changes (Table 1) . Two indicators of CSF inflammation, WBC count and protein level, were 24 higher in patients with encephalitis than encephalopathy, but viral loads or IgM titers in serum 25 or in CSF were not significantly different between these groups of patients (Table 2) . 1 Importantly, encephalitic cases required more intensive care support than NECACD cases 2 (Table 3) . 3
The cohort contained 21 adults (mean age, 63.9 years; SD, 15.6 years; range, 33-88 years) 4 and 36 infants (mean age, 1.6 month; SD, 1.15 month; range, 4 days -5.4 months). 5
Five infants were in the early neonatal period (< 7 days) and four in the late neonatal 6 period (7 to 28 days), corresponding to cases of mother-to-child and post-natal mosquito-7 borne transmission, respectively. 8
Infants were more likely to experience a recent onset of fever prior to hospitalization, 9 behavioral changes, skin rash, or survival and adults were more likely to experience decreased 10 consciousness, coma, focal neurologic signs, seizures, or a fatal issue (Table e-1) . Protein, 11 glucose and chloride CSF levels were higher in adults than infants (Table e-2) . CHIKV loads 12 in the CSF or serum were higher in infants than adults, whereas it was the opposite for IgM. 13 These results are in line with the fact that adults were observed later than infants in the course 14 of the CHIKV-associated CNS disease. CHIKV loads in the CSF and serum for infants and 15 between IgM levels in the CSF and serum from adults positively correlated (data not shown). 16
In infants, CHIKV loads in serum negatively correlated with age, while in adults IgM levels 17 in serum positively correlated with age (data not shown). 18
Except for one neonate exhibiting cerebral edema MRI features, no early (< 7 days) 19 diffusion-weighted (DWI) MRI scan was available for CHIKV-associated encephalitic cases, 20 although DWI is increasingly recognized as the most sensitive technique for timely diagnosis 21 of acute brain parenchyma inflammation. 22 Subsequently, no radiological image evocative of 22 acute stage of CHIKV-associated encephalitis was observed among the 22 other patients 23 submitted to brain CT scans, late MRI scans, or both. 24
Cumulative incidence rates of CHIKV-associated encephalitis 25
The overall CIR estimate of CHIKV-associated encephalitis was 8.6 per 100,000 persons 1 (95% CI: 6.9-10.4). Importantly, the age distribution pattern of CHIKV-associated CNS 2 disease (Figure 2a ) or CHIKV-associated encephalitis incidence (Figure 2b ) exhibited an U-3 shaped parabolic pattern with a very clear trend to the highest incidence towards the youngest 4 age than the oldest. 5
Prospective cohort study 6
Six adult patients died (mean, 67.5 years; SD, 15.7 years; range, 41-83 years) during 7 hospitalization (case fatality rate [CFR]: 10.5%). Detailed cause-specific mortality was as 8 follows: cardiac failure (n=2), septic shock (n=2), respiratory failure (n=1), sudden death 9 (n=1). Death certificates mentioned Chikungunya as the primary cause for degradation in 10 each case. As a consequence, 51 patients were eligible to the follow-up study. 11
Eight adults were discharged with neurological sequelae and are presented in Table e3 . 12
One deceased three months after discharge (case n°6). He was a 72-year old male individual 13 free from past medical history presenting altered mental status, classified as NECACD. He 14 deteriorated gradually towards dementia and deceased in a clinical picture of metabolic 15 encephalopathy due to dehydration and hypernatremia. EEG revealed a global slowdown 16 without spike. Sub-acute stage CT scans showed extensive demyelination and cerebral 17 subcortical atrophy. Four adult survivors were lost in follow-up and the ten others were 18 assessed clinically at three-year. Of these, we diagnosed three patients with neurological 19 sequelae (epilepsy, post-infectious dementia, cognitive disorder, respectively) and four with 20 an absence of detectable sequelae. 21
Nineteen infants were lost-to-follow up, and 17 evaluated at an average of 38 months of 22 age. One developed severe cerebral palsy and blindness. He was a full-term normal-for-23 gestational age boy free of obstetrical history presenting with hemorrhagic fever on day 4 of 24 life (case n°2, Table e3 ). Sub-acute and late stage MRI findings evidenced progressive 25 decrease of cerebral and cerebellar hemorrhages and replacement of brain edema features by 1 subsequent demyelination of the white matter, whose evolution contrasted with monophasic 2 or multiphasic patterns of acute disseminated encephalomyelitis (ADEM). Four infants 3 exhibited poor neurodevelopmental performances (Brunet-Lézine development quotients 4
[DQ] ≤ 85), irrespective of prenatal alcohol exposure, the other eight had age-related 5 appropriate skills (mean DQ: 98, SD: 9, range: 86-120). Of these five children, two were 6 infected vertically and three in the post-neonatal period (day 17, day 35 and day 73, 7 respectively) ( Table e3 ). The medical history of the lost-to-follow-up infants was uneventful, 8 except for one who developed Langherhans histiocytosis. 9
Given the high attrition in the follow-up and the risk for information bias, the burden of 10 neurological sequelae resulting from CHIKV-associated CNS disease could not be precisely 11 calculated and was estimated to be in the range of 17.6% (9/51) to 43.1% (22/51). 12
Nevertheless, lost-to-follow-up children corresponded to the milder forms of CNS disease so 13 that our estimates are likely conservative owing to the fact that the incidence of sequelae 14 often correlates with the intensity of the acute stage of infection in a previously healthy 15 population. For CHIKV-associated encephalitis, the CFR was 16.6% (4/24) and the three-year 16 burden of neurological sequelae in the range of 30% (6/20) to 45% (9/20). Importantly, we 17 observed an age difference in 3-year outcome of CHIKV-associated encephalitis, poor 18 prognosis (i.e., death or sequelae) being predominant in adults (52.6% vs 18.2%, P=0.020). with Japanese encephalitis. 25 
13
Though no similar study has been previously reported to our knowledge, our findings are 14 consistent with earlier report of CNS conditions complicating CHIKV infection, ranging from 15 mild neurocognitive or behavioral disorders to severe neurological syndromes including acute 16 stage encephalopathy/encephalitis, post-infective ADEM (e.g, encephalomyeloradiculitis) and 17 post-infective Guillain-Barré syndrome (e.g, polyradiculoneuritis).
14-17 They are also in 18 agreement with earlier observational studies, even though the criteria used to define 19 encephalitis differ from those we used.
5,26-28 CHIKV-associated CNS disease prognosis seems 20 similar to that of other viral etiologies. It was associated in our setting with more pejorative 21 figures than previously reported in India, 26, 27 or even recently in Thailand. 28 This substantial 22 toll is compatible with that of other virus-associated encephalitis. [29] [30] [31] 23 Interestingly, the age distribution of encephalitis incidence was U-shaped with two peaks 24 observed in young infants and elder adults, consistent with the distribution of encephalitis in 25 general populations, 21, 29, 30 or with overall neuroinvasive disease of viral origin reported in the 1 USA. 21 The CIR of CHIKV-associated encephalitis in these extreme age groups is 25-fold 2 higher for children under 1 year and 6-fold higher for people over 65 years than those found 3 for encephalitis of specified etiology in the USA. 21 This also contrasts the bimodal age 4 distribution of Herpes Simplex virus encephalitis which peaks between 60 and 64 years, 32 that 5 of WNV, which have a greater effect on the elderly, 24, 33 or that of La Crosse virus, which 6 targets rather the young children. 24, 34 Higher susceptibility of children to CHIKV-associated 7 encephalitis is also supported by the cerebral edema features observed in a neonate infected 8
by mother-to-child transmission. Accordingly, young mice are more susceptible to CHIKV 9 than adult mice. 35 In contrast to what observed in adults, CSF and serum of infants contained CHIKV RNA, 20 which is likely explained by their earlier presentation to hospital in our cohort. Moreover, the 21 higher the CHIKV load was in the serum, the higher it was in the CSF, and we made the same 22 observation in the adult with CHIKV-specific IgM (CSF/serum ratios smaller than one). 23
Therefore a passive diffusion of viral RNA or IgM from the serum to the CSF, either by 24 traumatic LP or as a result of a leakage in the blood-brain barrier, rather than CHIKV 1 replication or IgM production in the CNS, cannot be excluded. 2 Importantly, although infants appear more susceptible to CHIKV-associated encephalitis, 3 the clinical presentation and three-year outcome of CHIKV-associated encephalitis were more 4 severe in adults than in infants, except for one neonate. As also observed in the CHIMERE 5 cohort study, 40 they consisted exclusively in behavioral changes and neurocognitive 6 impairment in infants, while they affected cortical functioning and led to disabling sequelae in 7 adults. These data are in line with French national data and WNV encephalitis in the USA 8
showing milder presentation and better outcomes in children. 14 Third, we have not performed neuroradiologic examination routinely, so that 14 patients with mild neurologic forms were probably underestimated, while in turn, cases of 15 major CNS disease could be unstable to undergo timely MRI scans. Thus, as our study was 16 not population-based, we may have underestimated the real burden and slightly overestimated 17 the CFR and incidence of neurological sequelae. Fourth, the data collection was partially 18 retrospective and we may have missed some minor symptoms, such as tremors or other 19 movement disorders indicative of thalamic or basal ganglia involvement. 22 Thereby, we 20 focused on the symptoms whose presence was constantly notified, so that our description of 21 CHIKV-associated CNS disease is likely conservative and limit information bias. Fifth, our 22 study was restricted to a fairly localized area so that we cannot rule out the extent of CHIKV-23 associated CNS disease in recent years may reflect a stronger neurovirulence of the ECSA 24 sub-lineage. Encephalitis has not yet been described everywhere the ECSA genotype has 25 circulated. The occurrence of encephalitis may depend of the magnitude of the outbreak, by 1 targeting susceptible hosts to CHIKV-associated CNS disease. The study of host and CHIKV 2 genetic factors underlying CHIKV-associated CNS disease may help better understand the 3 pathogenesis of CHIKV-associated CNS disease. In this regard, we have much to learn from 4 current outbreaks throughout the world due to African and Asian lineages viruses. 5
We report here that CHIKV-associated CNS disease, including encephalitis as defined by 6 the IEC, may complicate CHIKV infection. Altogether these data contribute to improve the 7 knowledge of CHIKV-associated neuropathology and illustrates the clinical neurotropism of 8 CHIKV and its deleterious consequences, especially in neonates. 9
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